Dr. Mohile is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
601 Elmwood Ave
Rochester, NY 14642Phone+1 585-275-5863Fax+1 585-273-1051- Is this information wrong?
Summary
- Dr. Nimish Mohile is a neurologist in Rochester, NY and is affiliated with multiple hospitals in the area, including Highland Hospital and Strong Memorial Hospital of the University of Rochester. He received his medical degree from St. George's University School of Medicine and has been in practice 17 years. He specializes in neurooncology and is experienced in general neurology.
Education & Training
McGaw Medical Center of Northwestern UniversityResidency, Neurology, 2001 - 2004
Norwalk Hospital/Yale UniversityInternship, Internal Medicine, 2000 - 2001
St. George's University School of MedicineClass of 2000
Certifications & Licensure
NY State Medical License 2004 - 2026
IL State Medical License 2001 - 2005- American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012
Clinical Trials
- Memantine for Recurrent Glioblastoma Start of enrollment: 2010 Nov 01
- A Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma Start of enrollment: 2011 Dec 01
- Dose-Escalation Study of TPI 287 + Avastin Followed by Randomized Study of the Same Versus Avastin for Glioblastoma Start of enrollment: 2013 Aug 01
- Join now to see all
Publications & Presentations
PubMed
- Pilot trial testing the effects of exercise on chemotherapy-induced peripheral neurotoxicity (CIPN) and the interoceptive brain system.Ian R Kleckner, Thushini Manuweera, Po-Ju Lin, Kaitlin H Chung, Amber S Kleckner, Jennifer S Gewandter, Eva Culakova, Madalina E Tivarus, Richard F Dunne, Shelli R Kes...> ;Research Square. 2024 Mar 13
- Practical guidance for direct oral anticoagulant use in the treatment of venous thromboembolism in primary and metastatic brain tumor patients.Ranjan, S., Leung, D., Ghiaseddin, A., Taylor, J., Lobbous, M., Dhawan, A., Budhu, J., Coffee, E., Melnick, K., Chowdhary, S., Lu-Emerson, C., Kurz, S., Burke, J., Lam...> ;Cancer. 2024 Jan 30
- Phase 1 trial of TPI 287, a microtubule stabilizing agent, in combination with bevacizumab in adults with recurrent glioblastoma.Goldlust, S., Duic, P., Benkers, T., Singer, S., Rao, M., Cappello, L., Silberman, S., Farmer, G., Nabors, L., Hsu, S., Mohile, N.> ;Neuro-Oncology Advances. 2024 Jan 18
- Join now to see all
Press Mentions
- Glioma Signature Predicts Outcomes in GlioblastomaJune 1st, 2016
Glioma Signature Predicts Outcomes in GlioblastomaJune 1st, 2016
Hospital Affiliations
Highland HospitalRochester, New York
Strong Memorial Hospital of the University of RochesterRochester, New York
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
